Repare Therapeutics/$RPTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Repare Therapeutics
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
Ticker
$RPTX
Sector
Primary listing
Employees
129
Headquarters
Montreal, Canada
Website
RPTX Metrics
BasicAdvanced
$81M
-
-$2.58
0.93
-
Price and volume
Market cap
$81M
Beta
0.93
52-week high
$3.60
52-week low
$0.89
Average daily volume
140K
Financial strength
Current ratio
6.302
Quick ratio
6.178
Total debt to equity
0.588
Profitability
EBITDA (TTM)
-110.471
Gross margin (TTM)
6,145.60%
Net profit margin (TTM)
-43,945.60%
Operating margin (TTM)
-45,450.00%
Effective tax rate (TTM)
-1.01%
Management effectiveness
Return on assets (TTM)
-38.82%
Return on equity (TTM)
-69.96%
Valuation
Price to revenue (TTM)
320.546
Price to book
0.73
Price to tangible book (TTM)
0.73
Price to free cash flow (TTM)
-0.783
Free cash flow yield (TTM)
-127.72%
Free cash flow per share (TTM)
-2.401
Growth
Revenue change (TTM)
-99.64%
Earnings per share change (TTM)
58.87%
3-year revenue growth (CAGR)
-68.81%
3-year earnings per share growth (CAGR)
-7.70%
What the Analysts think about RPTX
Analyst ratings (Buy, Hold, Sell) for Repare Therapeutics stock.
RPTX Financial Performance
Revenues and expenses
RPTX Earnings Performance
Company profitability
RPTX News
AllArticlesVideos
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Business Wire1 week ago
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Repare Therapeutics stock?
Repare Therapeutics (RPTX) has a market cap of $81M as of October 22, 2025.
What is the P/E ratio for Repare Therapeutics stock?
The price to earnings (P/E) ratio for Repare Therapeutics (RPTX) stock is 0 as of October 22, 2025.
Does Repare Therapeutics stock pay dividends?
No, Repare Therapeutics (RPTX) stock does not pay dividends to its shareholders as of October 22, 2025.
When is the next Repare Therapeutics dividend payment date?
Repare Therapeutics (RPTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Repare Therapeutics?
Repare Therapeutics (RPTX) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.